Ziopharm_RGB_hires (1).jpg
Ziopharm Oncology Announces Strategic Reduction in Workforce and Extension in Cash Runway
September 27, 2021 16:05 ET | ZIOPHARM Oncology Inc
• Over 50% reduction in personnel • Cost reductions expected to extend the cash runway into the first half of 2023 • The first patient in its TCR-T Library Phase I/II clinical trial is expected to...
Ziopharm_RGB_hires (1).jpg
Ziopharm Oncology to Participate in September Investor Conferences
September 01, 2021 16:05 ET | ZIOPHARM Oncology Inc
BOSTON and HOUSTON, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), today announced that Kevin S. Boyle, Sr., Chief Executive Officer of...
Ziopharm Oncology Appoints Kevin S. Boyle, Sr., as Chief Executive Officer and Announces other Executive Promotions
August 30, 2021 08:30 ET | ZIOPHARM Oncology Inc
Mr. Boyle brings over 20 years of executive business leadership in CEO, CFO and operational leadership roles Strong track record of successfully guiding companies and creating shareholder value...
Ziopharm_RGB_hires (1).jpg
Ziopharm Oncology Provides Second Quarter 2021 Corporate Updates
August 09, 2021 16:05 ET | ZIOPHARM Oncology Inc
Accomplished key milestones in groundbreaking TCR-T Library program, including commissioning of Company’s manufacturing facility and presentation of favorable preclinical data Closed venture debt...
Ziopharm_RGB_hires (1).jpg
Ziopharm Oncology to Report Second Quarter Financial Results on August 9, 2021
July 26, 2021 16:30 ET | ZIOPHARM Oncology Inc
BOSTON, July 26, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced that management will host a conference call and webcast on Monday, August 9, at 4:30 p.m. EDT to...
Ziopharm_RGB_hires (1).jpg
Ziopharm Oncology to Participate in Upcoming Conferences
May 24, 2021 16:05 ET | ZIOPHARM Oncology Inc
BOSTON, May 24, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), a clinical-stage cellular therapy company focused on hematologic and solid tumor...
Ziopharm_RGB_hires (1).jpg
Ziopharm Oncology Reinforces Clear and Bold Vision for Delivering Value at Annual Shareholders Meeting
May 19, 2021 16:05 ET | ZIOPHARM Oncology Inc
– Highlighted distinctive cellular therapy program, market opportunity and value proposition – Shared optimistic outlook and commitment to deliver value to shareholders – Encouraged by overwhelming...
Ziopharm_RGB_hires (1).jpg
Ziopharm Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Updates
May 06, 2021 16:02 ET | ZIOPHARM Oncology Inc
– Annual shareholder meeting planned for May 19, 2021 – Company to host conference call today at 4:30 pm ET BOSTON, May 06, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the...
Ziopharm_RGB_hires (1).jpg
Ziopharm Oncology Scientific Advisor Laurence Cooper, MD, PhD, to Present at University of Pennsylvania Cellicon Valley ’21 Two-Day Live Virtual Educational Symposium
May 04, 2021 08:00 ET | ZIOPHARM Oncology Inc
BOSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (“Ziopharm” or the “Company”) (Nasdaq: ZIOP), announced today that Laurence J.N. Cooper, PhD, MD, Scientific Advisor to the Company,...
Ziopharm_RGB_hires (1).jpg
Ziopharm Oncology to Report First Quarter Financial Results on May 6, 2021
April 29, 2021 09:00 ET | ZIOPHARM Oncology Inc
BOSTON, April 29, 2021 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq: ZIOP), today announced it will report first quarter 2021 financial results on Thursday, May 6, 2021 after the financial...